Skip to main content

Varithena FDA Approval History

FDA Approved: Yes (First approved November 25, 2013)
Brand name: Varithena
Generic name: polidocanol
Dosage form: Injectable Foam
Company: BTG plc
Treatment for: Varicose Veins

Varithena (polidocanol) injectable foam is a sclerosing agent indicated for the treatment of varicose veins.

Development timeline for Varithena

Nov 26, 2013Approval FDA Approves Varithena (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.